Note: This article was originally published by CBC on February 12, 2021, featuring Dr. Belinda Heyne, Singletto’s Chief Photochemist.
Researchers at University of Calgary participating in global study to ease PPE shortages
It's a novel application of a simple solution — and should it be effective, it could have an impact on mask shortages on a global scale.
Belinda Heyne, professor of chemistry at the University of Calgary, is part of a team who worked to develop a new method that uses a cheap blue dye and light in order to decontaminate medical masks.
"The dye, which is called methylene blue, [is] activated by indoor light. The methylene blue, through its activation, is enabling to take out the energy of the light and giving it to the ambient oxygen that we have around us," Heyne said.
"That's energizing oxygen, and then the oxygen is becoming reactive, and this is what is killing the virus.”
Continue reading on CBC.CA.
The Infection Control & Hospital Epidemiology medical journal has published the peer-reviewed DeMaND study. Singletto’s Dr. Tom Lendvay served as Lead Author.
Mike Butler spent over two decades in leadership at Providence Health, growing such from a $2 billion organization to $25 billion. Upon recently retiring, Mike knew he wanted to find ways to continue impacting the lives and health of others. Now at Singletto, Mike is on a mission to bring the novel Singletto technology to market – in healthcare and beyond. But, it’s not just a passion project … upon learning about the technology, Mike felt a moral obligation to get it in as many hands as possible. More with recently retired Providence Health President Mike Butler…
Dr. Belinda Heyne was recently featured in a CBC piece covering the DeMaND study’s findings and the life-giving potential of dye and light.